In spite of these promising observations on the therapeutic potential of fibrocytes in
diabetic ulcers, the allogeneic transplantation of normal circulating
fibrocytes in diabetic patients is not feasible because of the low
number of cells in normal peripheral blood , their limited
proliferation potential under standard culture conditions ,
and their antigen-presenting function